Showing results (1451-1460 of 1,710) with videos related to

Sort By:
Pageof 171
Nature Biomedical Engineering|July 20, 2023
Oxonium ion scanning mass spectrometry for large-scale plasma glycoproteomicsMatthew E H White, Ludwig R Sinn, D Marc Jones, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2021
Multispecific targeting of glioblastoma with tumor microenvironment-responsive multifunctional engineered NK cellsJiao Wang, Sandra Toregrosa-Allen, Bennett D Elzey, et al.
Cancer Research|September 25, 2020
Chromothripsis in Human Breast CancerMichiel Bolkestein, John K L Wong, Verena Thewes, et al.
European Journal of Radiology|February 22, 2023
Neoadjuvant immune-checkpoint inhibitors in lung cancer - a primer for radiologistsDaria Kifjak, Maximilian J Hochmair, Dagmar Krenbek, et al.
Cell Reports. Medicine|November 20, 2024
Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancerCarsten Denkert, Andreas Schneeweiss, Julia Rey, et al.
Systematic Biology|October 6, 2025
Nuclear Phylogenomic Insights into Relationships, Support, and Conflict Among the Early Diverging Lineages of the Megadiverse Epidendroid OrchidsCraig F Barrett, John V Freudenstein, Samuel V Skibicki, et al.
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi|September 25, 2023
Risk of Hepatitis C Virus Transmission through Acupuncture: A Systematic Review and Meta-AnalysisMyung Han Hyun, Ji Hoon Kim, Jeong Won Jang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendationsManfred Kaufmann, Gunter von Minckwitz, Roy Smith, et al.
Journal of Synchrotron Radiation|September 8, 2022
The soft X-ray monochromator at the SASE3 beamline of the European XFEL: from design to operationN Gerasimova, D La Civita, L Samoylova, et al.
Breast Cancer Research : BCR|February 9, 2013
HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancerCarsten Denkert, Jens Huober, Sibylle Loibl, et al.
Pageof 171